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Objective: To investigate the relationship of orofacial dysfunction and salivary cortisol levels
with oral health quality of life (ORHQoL) in young adults.
Design: Thirty individuals of both genders (22.93  2.42 years) participated. The orofacial
dysfunction was evaluated using the Nordic Orofacial Test-Screening (NOT-S) and the
ORHQoL using the Oral Health Impact Profile (OHIP-49). Saliva samples were collected
during three days, at waking up and 30 min after, obtaining the awakening cortisol response
– ACR. The data were analysed byMann–Whitney test, Spearman’s correlation andmultiple
linear regression (a = 0.05). The NOT-S scores and ACR (mg/dl) were dichotomized by the
median (2.0 and 0.15, respectively).
Results: NOT-S and ACR showed similar values between genders (P > 0.05). The individuals
with NOT-S scores above the median presented values of ‘‘physical pain’’ domain signifi-
cantly higher than the individuals with scores bellow or equal to the median. Significant
correlations were found between the OHIP-49 domains ‘‘physical pain’’ and ‘‘physical
disability’’ and NOT-S scores. Inmultiple linear regression, significant values were observed
between NOT-S and OHIP-49 and the domains physical pain, physical disability, psycho-
logical disability, social disability and handicap, with determination coefficients ranging
from 0.09 to 0.15. There was not association with the ACR.
Conclusions: Individuals with orofacial dysfunction presented impairment in ORHQoL, but
not enough to change salivary cortisol levels. Furthermore, gender did not have influence on
ORHQoL in the studied sample.
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The quality of life (QoL) can be defined, as the perception of the
individuals about their position in life, embedded in a cultural
context and a value system in relation to their goals,
expectations, standards and concerns.1 The general health
appears as a one-dimensional concept that has its attention
focused on isolated parts in the search for disease and repair of
these,2 thus disregarding mental and social elements that
might affect it.3
Thus the concept of oral health has undergone a similar
development. In the past, the main focus in dental research
also lay on objective outcomes (dental caries or periodontal
disease). It is now recognized that, as with general health,
these outcomes do not provide an adequate measure of oral
health because they neglect the multidimensional character
of oral health and its effect on QoL.4 Similarly, physical
changes localized in specific regions of the bodymay interfere
with the overall health, affecting the quality of life.
Orofacial function is the result of complex integrated
activities of the central nervous system and the neuromuscu-
lar system5 and includes a multitude of vital actions such as
breathing, chewing and swallowing, acting as the basis for
social interaction in terms of speech, emotional communica-
tion, facial expression and appearance.6 It may be impaired by
several factors including orofacial dysfunctions, which sug-
gests a need for understanding the influence of individual and
environmental factors in relation between health/quality of
life.
Individuals with disable oral conditions reported impacts
in emotional and social welfare being exposed to stressful
situations that, physiologically, lead to increased plasma
hormone, such as catecholamines and cortisol. These physio-
logical responses to emotional stressful factors aim to prepare
the body to face the physical or psychological threat, deviating
the glucose use for the central nervous system, increasing the
cardiac output and suppressing peripheral functions, non-
essential, as digestive, immune and reproductive.7 Such
reactions are triggered by the activation of hypothalamic–
pituitary–adrenal axis and sympatho-adrenomedullary (SAM)
system that are responsible amongst other functions by the
release of cortisol and catecholamines, respectively.
The cortisol is a key hormone in response to agent physical
and psychosocial stressors8 that, in repeated exposure to
stressful situations, can trigger the secretion of excess leads to
detrimental effects on health.9
Changes in cortisol concentrations can be observed during
the first hours after waking,10,11 and the peak being reached
after 30–45 min post-awakening,10,12 with decreasing concen-
trations thereafter,13 being very low in the evening and at
night.14 In addition, hormonal peaks may also be observed
when the body is exposed to exercises, food and tobacco.14
The difference in hormonal concentration between the
peak hours and the time of awakening is identified by
Pruessner et al.15 as the awakening cortisol response. In other
words, is calculated as the concentration difference between
+30 min post-awakening and awakening,16 which shows as a
reliable biological marker of the hypothalamic–pituitary–
adrenocortical (HPA) axis with high stability and so may beused to measure the level of psychological tension in daily
life.15
ACR is a reliable biologicalmarker of HPA activity with high
intra-individual stability and therefore it can be used to
measure the level of psychological strain in daily life. The
activity of this hormone is evaluated by technique for
quantification of salivary cortisol, and the saliva collection
made by a simple method,17 non invasive and stress free, that
can be performed in a domestic environment.18,19
Considering the information cited above, it becomes crucial
to analyse factors that can affect the operation of biological
structures, especially those related to physiological oral
functions. So, the presence of orofacial dysfunctions may
influence the welfare of patient affecting the quality of life
with the possibility of changing in salivary cortisol levels. In
this way, the aim of this study was to investigate if there is
relationship between orofacial dysfunction and salivary
cortisol levels with quality of life in young adults.2. Materials and methods
The sample comprised 30 students (15 males and 15 females)
from Piracicaba Dental School – University of Campinas (FOP–
UNICAMP), Piracicaba, SP, Brazil, aged from eighteen to
twenty-five years (22.93  2.42 years). The Ethical Committee
of the Dental School of Piracicaba approved the study, and all
participants gave verbal and written permission to carry out
the research (protocol no. 053/2009).
The sample size was calculated by taking into account the
results found by Garcia et al.20 for a power test of 0.90 with an
alpha level of 0.01, and 24 subjectswere found to be a sufficient
number. Additional subjects were added to account for
dropouts.
The exclusion criteria included the use of drugs that could
affect muscle activity, directly or indirectly, such as anti-
histamines, sedatives, syrups, homoeopathy, or drugs that
depress the central nervous system; presence of disorders of
systemic origin that could compromise the masticatory
system, such as neurological disorders, cerebral palsy,
amongst others; and also the use of drugs that interfere with
saliva flow and hormone levels, such as sedatives, anti-
inflammatory drugs and corticosteroids.
2.1. Evaluation of orofacial function
The presence of orofacial dysfunctionwas evaluated using the
Nordic Orofacial Test-Screening (NOT-S), a consistent and
valid instrument and cultural adapted to Portuguese (Brazil)
language by Leme and Gavia˜o.21
Twelve topics related to orofacial dysfunction were
considered, and six assessed by structured interview and
six evaluated during the clinical examination. The domains
assessed by interviewwere: (I) sensory function, (II) breathing,
(III) habits, (IV) chewing and swallowing, (V) drooling and (VI)
dryness of the mouth. The domains evaluated by the clinical
examination were: (1) face at rest, (2) nose breathing, (3) facial
expression, (4) masticatory muscle and jaw function, (5) oral
motor function and (6) speech. Each domain contains one to
five items, reflecting the complexity of the specific function.
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individually by the first author (PJSAS) in a separate room in
the Dental School. NOT-S interview was carried out by asking
the questions in the ‘‘Screening form’’. For assess orofacial
dysfunction in clinical examination, the subjects were
requested to make tasks on each item. The clinical examina-
tion was carried out in conjunction with the illustrate manual
(www. mun-h-centre.se). Each item has criteria for the
respective function. An answer YES or task that meet the
criteria for impaired function gave the score 1, thus indicating
a dysfunction in the scored domain; answer NO or task that
did not meet the criteria, gave the score 0. The total score was
the sumof the score of each domain, and could range from0 to
12.6,22
2.2. Evaluation of quality of life related to oral health
The Oral Health Impact Profile (OHIP-49), a questionnaire to
evaluate the quality of life related to oral health was used,
duly translated into Portuguese and adapted considering the
cultural differences in Brazil.23 This questionnaire was
administered in a private room by the same investigator
that provided previously defined explanations for all
participants.
The OHIP-49 is divided into seven different domains, each
one ranged as follows: functional limitation (9 items) from 0 to
36; physical pain (9 items) from 0 to 36; psychological
discomfort (5 items) from 0 to 20; physical disability (9 items)
from 0 to 36; psychological disability (6 items) from 0 to 24;
social disability (5 items) from 0 to 20; handicap (6 items) from
0 to 4; and finally overall OHIP score (49 items) from 0 to 196
points. In this model, higher scores indicate a poorer state of
health.24 Possible answers to the items were never, hardly
ever, occasionally, often, and very often experienced in the
last month – using a five-point Likert scale (0 = never, 4 = very
often). The summary score (simple addition; minimum 0,
maximum 196) was taken as an overview of OHRQoL.25,26 The
respective results were presented as OHIP-SUM.26
2.3. Cortisol assay
2.3.1. Salivary cortisol assessment
The saliva samples were collected during three days in two
different moments, one after wake up and the other 30 min
after the first one (due to peak cortisol at this time) at home.
The samples were stored into a refrigerator and delivered to
the researcher in the sameday at the PiracicabaDental School.
The instructions about the procedure were explained to
each participant and Polypropylene numbered tubes were
provided (Salivette1, Sarstedst, Nu¨mbrecht, Germany) for
saliva collection at home. Subjects were asked not to perform
physical exercises or ingestion of caffeinated beverages a day
earlier. They should also abstain from food, beverages and
brushing teeth at the time of sampling allowing only water
intake.14
The saliva collection was done through sterile cotton roller
placed under the tongue of the subject for 3–4 min. They
should use one glove for each collection and if there were
visible signs of blood in the samples, they would be discarded
due to possible contamination of plasma cortisol.272.3.2. Laboratory procedure
The salivettes were centrifuged at 3500 rpm for 5 min and the
debris discarded, only the supernatant was used. The samples
were stored at 40 8C until hormone measurement was
performed. The salivary cortisol was measured by enzyme
immunoassay kit (EIA – HSCortisol) (product no. 1-1102;
Salimetrics, State Colegge, PA, USA) at room temperature
(25 8C). The volumes were 25 ml of samples and the incubation
time was 55 min.
The samples were measured in duplicate, so that the
samples from the same individual were assayed in the same
test. The procedure follows the basic principle of enzyme
immunoassay, where a competition between the unlabeled
antigen and an enzyme-labelled antigen for a fixed number of
binding sites on the antibody was done. The analysis was
performed by reading the absorbance of the solution, using a
microplate reader set at 450 nm (with correction capability of
dual-wavelength 600/620 nm).28,29
The cortisol results were expresses as ‘‘awakening cortisol
response’’ (ACR, mg/dl).
2.4. Statistical analysis
The values were analysed using the software programmes
Microsoft1 Excel, Bioestat Version 5.0 and SPSS Version 16.0.
The Shapiro–Wilk test was applied to verify the data
distribution and normality. The data were not normally
distributed and despite transformations were applied, the
normality was not achieved; thus, non-parametric tests were
used.
The variables NOT-S and ACR (mg/dl) were dichotomized,
considering the median values, which were calculated to
determinate the centre scores, showing values above,
equals and bellow of the respective medians. These
analyses were undertaken for the comparison of the
variables and verification of statistically relation between
NOT-S and ACR (mg/dl) in relation to the median of OHIP-
SUM and OHIP-49 domains.
Thus, the Chi-Square test was used to verify the sample
distribution according to the previous variables. All P-values
0.05 were defined as significant. Moreover, the Mann–
Whitney test was applied to analyse the differences between
means of the total score of OHIP-49 and the seven domains
with the variables including gender, age, NOT-S and ACR
(Table 1).
Spearman’s rank correlation coefficients were used to
assess the correlations between the OHIP total and domain
scores with NOT-S scores and ACR values. Next, multiple
linear regression analyses was undertaken of OHIP-SUM and
its domains scores as dependent variables with the other
variables of this study cited above. All variables, including
gender, age, NOT-S and ACR, were used in the regression
analyses with the OHIP-49 as a dependent variable. This
approachwasused tomanage confounding.Confoundingcan
result in an overestimation or underestimation of the
strength of the association between exposure and outcome
variables and can change the direction of the relationship.
Consequently, variables that are not significant at the
bivariate level can emerge as being significant inmultivariate
analysis.
Table 1 – Sample distribution in accordance with the evaluated characteristics–number of individuals.
Characteristics Male Female Total Range
Gender 15 (50%) 15 (50%) 30 –
Age (years) 23.80  1.4 22.1  2.9 22.93  2.42 –
NOT-S 1.80  1.46 1.93  1.22 1.80  1.35 0–5
Median (2.0) n = 11 1.18  0.87 n = 11 1.36  0.81 22 (73.3%) –
>Median (2.0) n = 4 3.75  0.96 n = 4 3.50  0.58 8 (26.7%) –
ACR (mg/dl) 0.15  0.09 0.19  0.13 0.17  0.11 0.02–0.49
Median (0.15) n = 8 0.09  0.05 n = 7 0.10  0.03 15 (50%) –
>Median (0.15) n = 7 0.22  0.07 n = 8 0.28  0.11 15 (50%) –
NOT-S, Nordic Orofacial Test Screening; ACR, awakening cortisol response.
*P-value > 0.05 obtained from Chi-Square test.
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In accordance of the proposal methods, the sample distribu-
tion in relation to gender, analysed by Chi-Square test, was
homogeneous (P > 0.05), as well as for individuals having
values of NOT-S and ACR above and below or equals the
median. The NOT-S scores ranged from 0 to 5 and the most
compromised function and the most affected prevalent
domains in the interview were the ‘‘habits’’ and ‘‘chewing
and swallowing’’, and in the examination was ‘‘face at rest’’
followed by the ‘‘masticatory muscle and jaw function’’.
In Table 2, it is verified that individuals with the highest
scores of NOT-S, i.e., higher than the median (2.0) showed
higher scores for the OHIP-49 subcategory ‘‘physical pain’’,
denoting that orofacial dysfunction may interfere in pain
perception and consequently in this domain.
According to Table 3, the correlations between physical
pain and physical disability domains of OHIP-49 and NOT-S
were statistically significant, demonstrating an influence of
the orofacial dysfunction on physical conditions. The ACR did
not show significant correlation with the NOT-S domains.
Table 4 shows the results of the multiple linear regression
analysis predicting OHIP total and domains scores. It can be
observed a significant interrelationship between orofacial
disturbance and total scoreOHIP-49 and someof its dependent
variables, such as ‘‘physical pain’’, ‘‘physical disability’’,
‘‘psychological disability’’, ‘‘social disability’’ and ‘‘handicap’’
domain.Table 2 – OHIP total and domains scores by categories of gend
Variable n OHIP-SUM
Functional
limitation
Physical
pain
Psych
disc
Gender
Male 15 13.8 (20.1) 2.7 (3.5) 4.3 (4.5) 2.
Female 15 10.7 (11.3) 3.2 (4.2) 4.3 (3.2) 1.
NOT-S
Median (2.0) 22 9.3 (12.2) 2.5 (3.5) 3.5 (3.3)* 1.
>Median (2.0) 8 20.5 (22.9) 4.4 (4.5) 6.8 (4.4)* 2.
ACR (mg/dl)
Median (0.15) 15 10.4 (12.9) 2.2 (3.1) 4.1 (3.5) 2.
>Median (0.15) 15 14.1 (19.1) 3.7 (4.4) 4.6 (4.3) 1.
OHIP-SUM, Oral Health Impact Profile-sum score; NOT-S, Nordic Orofaci
* P < 0.05 (obtained from Mann–Whitney test).4. Discussion
The participants of this study comprised 15 males and 15
females, aged from 18 to 25 years. They composed a
homogeneous sample in relation to gender and age, the last
one demonstrated by the low standard deviation, i.e.,
22.93  2.42 years. Because this, the age was not considered
for comparisons amongst the other variables. Nevertheless,
since it has been observed in the literature differences
betweenmales and females, the respective comparisons were
carried out. In order to do the statistical analysis properly, the
NOT-S scores and ACR values were dichotomized considering
theirmedians. In thisway, the sample showedhomogeneity in
relation to those variables, since there were no different
proportions of individuals with values above and below or
equals the respectivemedians, allowing us to perform reliable
tests.
The NOT-S scores were low, differing from Bakke et al.,6
who found higher values in a clinic-referred sample of centres
for specialized dental care and clinics for speech pathology.
The respective difference can be due to the sample char-
acteristics, i.e., our sample was composed by healthy
individuals, but the most of them with malocclusion, which
could have influence on orofacial function. In addition, there
were no differences in NOT-S scores between genders, as well
as for the ACR levels. It was observed that on the work day,
women showed larger increases than men, but there were no
gender differences on the weekend day; moreover, anticipa-er, age, NOT-S and salivary cortisol levels.
OHIP subcategories
ological
omfort
Physical
disability
Psychological
disability
Social
disability
Handicap
2 (4.0) 1.7 (3.7) 1.4 (2.3) 0.5 (1.3) 1.0 (2.9)
8 (2.5) 0.8 (1.9) 0.5 (1.1) 0.1 (0.4) 0.0 (0.0)
7 (3.1) 0.6 (1.6) 0.7 (1.4) 0.1 (0.4) 0.2 (0.7)
9 (3.8) 2.9 (4.9) 1.5 (2.8) 0.8 (1.8) 1.4 (3.9)
1 (3.4) 0.7 (1.7) 0.9 (1.4) 0.1 (0.4) 0.2 (0.8)
9 (3.2) 1.7 (3.8) 0.9 (2.3) 0.5 (1.3) 0.8 (2.8)
al Test Screening; ACR, awakening cortisol response.
Table 3 – Correlations between OHIP total and domain
scores, NOT-S scores and the awakening cortisol re-
sponse (n = 30).
NOT-S scores ACR (mg/dl)
r P-value r P-value
OHIP-SUM 0.34 0.059 0.05 0.786
OHIP subcategories
Functional limitation 0.32 0.082 0.08 0.653
Physical pain 0.43 0.016* 0 0.966
Psychological discomfort 0.18 0.332 0.08 0.640
Physical disability 0.36 0.046* 0.04 0.826
Psychological disability 0.26 0.154 0.19 0.305
Social disability 0.22 0.229 0.09 0.618
Handicap 0.24 0.195 0.11 0.549
OHIP-SUM, Oral Health Impact Profile-sum score; NOT-S, Nordic
Orofacial Test Screening, ACR, awakening cortisol response.
r, Spearman’s correlation coefficient.
* P < 0.05.
Table 4 – Results of multiple linear regression analysis
predicting OHIP total and domains scores.
Dependent variable: OHIP-SUM
Independent variables B P
Gender (male = 0; female = 1) 0.488 0.629
Age (in years) 0.183 0.855
NOT-S scores 2.699 0.012*
ACR (mg/dl) 0.043 0.965
Adjusted R2 = 0.137
Dependent variable: OHIP domain ‘‘functional limitation’’
Independent variables B P
Gender (male = 0; female = 1) 0.183 0.855
Age (in years) 0.000 1.000
NOT-S scores 1.635 0.114
ACR (mg/dl) 0.362 0.720
Adjusted R2 = 0.014
Dependent variable: OHIP domain ‘‘physical pain’’
Independent variables B P
Gender (male = 0; female = 1) 0.164 0.870
Age (in years) 0.457 0.651
NOT-S scores 2.802 0.009*
ACR (mg/dl) 0.134 0.893
Adjusted R2 = 0.140
Dependent variable: OHIP domain ‘‘psychological discomfort’’
Independent variables B P
Gender (male = 0; female = 1) 0.304 0.763
Age (in years) 0.200 0.842
NOT-S scores 1.613 0.119
ACR (mg/dl) 0.557 0.581
Adjusted R2 = 0.022
Dependent variable: OHIP domain ‘‘physical disability’’
Independent variables B P
Gender (male = 0; female = 1) 1.353 0.187
Age (in years) 0.342 0.911
NOT-S scores 2.403 0.023*
ACR (mg/dl) 0.157 0.876
Adjusted R2 = 0.150
Dependent variable: OHIP domain ‘‘psychological disability’’
Independent variables B P
Gender (male = 0; female = 1) 1.353 0.187
Age (in years) 0.112 0.911
NOT-S scores 2.403 0.023*
ACR (mg/dl) 0.157 0.876
Adjusted R2 = 0.118
Dependent variable: OHIP domain ‘‘social disability’’
Independent variables B P
Gender (male = 0; female = 1) 0.849 0.403
Age (in years) 0.579 0.567
NOT-S scores 2.509 0.018*
ACR (mg/dl) 0.410 0.684
Adjusted R2 = 0.087
Dependent variable: OHIP domain ‘‘handicap’’
Independent variables B P
Gender (male = 0; female = 1) 1.406 0.171
Age (in years) 0.032 0.974
NOT-S scores 2.546 0.017*
ACR (mg/dl) 0.002 0.997
Adjusted R2 = 0.105
OHIP-SUM: Oral Health Impact Profile-sum score.
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response, inferring that cortisol output over the early part of
the day may be particularly sensitive to the influence of
chronic stress and its anticipation, especially in women.30 On
the other hand, Takai et al.8 observed that after a stressful
video viewing the cortisol levels in highly anxious females
were significantly lower than those in highly anxious males,
suggesting that high trait anxiety in females may be
associated with an inability to respond with sufficient
activation of HPA under acute psychological stress. These
contrasting findings were considered by Chida and Steptoe19
who observed in a meta-analysis that different psychosocial
factors are associated both with an enhanced and reduced
ACR.
In order to compare the OHIP domains scores, considering
the orofacial dysfunction, the median value of NOT-S was
taken into account to categorize this variable, as stated above.
The results showed that the individuals with NOT-S values
above the median presented higher values of OHIP-SUM,
inferring that orofacial dysfunction can be an influencing
factor on ORHQoL. This way, on comparing the OHIP domains,
the physical pain was the domain that determined differences
between the individuals.Moreover, this domainwaspositively
correlated with the total NOT-S scores (Table 3). According to
this study, it is possible to verify that higher scores of NOT-S
inferred in worse ORHQoL related to physical domains of
OHIP-49, demonstrating that the NOT-Smay be used as useful
screening instrument for evaluation of orofacial dysfunction
and for presupposed damages in quality of life. Hassel et al.30
found association between the somatization with all domains
of OHIP-49 from functional aspects to psychological and
social, observing the largest amount of additional explainable
variance in the domain physical pain, expected because both
measures capture complaints about pain. Similarly in this
research, results of themultiple linear regression showed that
the OHIP-49 domains related to physical and psychological
aspects, considered as dependent variables into the model,
was significantly associated with the NOT-S scores, as
independent variable (Table 4). Nevertheless, the values of
the determination coefficients (R2) showed that the influenceof orofacial dysfunctions on ORHQoL were low, from 8% to
15%. This means that other factors must be influencing the
ORHQoL in the studied sample. Moreover, this little influence
is in line with the no difference in the ACR values.
Individuals presenting ACR values above the median did not
show different scores of OHIP-49 than individuals with values
bellow or equals to the median. The detected orofacial dysfunc-
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above, but they could not been so severe and consequently not
enough to achieve significant differences amongst the dichoto-
mizedgroups intherespectivedomains.Thecortisol levelsmight
be influenced by several factors including the adversity in
chronic stressors and negative life events.16,19 This study did not
aim to evaluate the stressor severity, duration, and repetitive
exposure, age of exposure or context.Nevertheless, these factors
indicate an accumulation of adversity that might be of impor-
tance for thedevelopmentofdivergent trajectoriesof cortisolup-
and possibly down-regulation.16
According to the findings, a significant correlation occurred
between NOT-S scores and the physical pain and physical
disability domains of the OHIP-49. Despite the correlation
coefficients had been low, indicating weak correlations, it is
possible to confirm that orofacial dysfunction was an influent
factor on ORHQoL that is in line with the comparisons
achieved between the dichotomized groups considering the
NOT-S scores (Table 2).
The OHIP-49 did not achieve significant correlation with the
ACR, indicating that oral health did not have influence on
cortisol secretion in the studied sample. Maybe the severity of
the detected orofacial dysfunctions was not enough for
increasing salivary cortisol levels, i.e., the respective dysfunc-
tions did not cause considerable impact on individual’s life not
influencing the stress levels. On the other hand, Some studies
have shown association between psychosocial19 and psycholog-
ical31 factorsandcortisol levels, being that themajorpartof them
approach general aspects of life, stress situations, emotional
distress, anxiety and depression13,14,32 and our analyses did not
focus in it.Furthermore, thoseaspectsshouldbeverifiedinfuture
studies in general population, since we worked with a sample
composed by students from FOP–UNICAMP, that could be
considered a limitation of the present study.
Concluding, the OHIP-49 and NOT-S presented significant
correlation. Despite the influence of orofacial dysfunctions
had been small, it was possible to infer that the individuals
with orofacial dysfunctions (higher scores of the NOT-S)
presented impairment in quality of life related to oral health,
but not enough to increase salivary cortisol levels. Further-
more, gender did not have influence on oral health quality of
life in the studied sample.Funding
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